A 74-year-old woman with rheumatoid arthritis was urgently admitted to our hospital due to dyspnea. The patient received methotrexate at a dose of 4 mg/week, filgotinib at 200 mg/day and prednisolone at 5 mg/day. On admission, chest CT findings showed diffuse ground glass attenuation in both lung fields; we diagnosed acute exacerbation of interstitial lung disease. Treatment was initiated with prednisolone at 60mg/day; the dose was tapered as the patient’s condition improved. Drug-induced pneumonia was suspected in this case based on laboratory data and clinical course; however, it was difficult to differentiate whether the causative agent was methotrexate, filgotinib, or both.
View full abstract